Carfilzomib 56 MG [Kyprolis]
SMC-2021-03-147
Phase 2 small_molecule active
Quick answer
Carfilzomib 56 MG [Kyprolis] for Multiple Myeloma is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active